Stryker has made 5 acquisitions for $2.4B+ in 2018 so far — Here is the timeline

Written by Laura Dyrda | October 04, 2018 | Print  |

Stryker has made big moves in 2018, especially over the past three months, to grow the company across several business lines.

Here is a timeline of all the moves Stryker has made this year:

February 28: Stryker acquired Entellus, a high-growth global medical technology company focused on minimally invasive ENT treatment, for around $662 million, or $24 per share.

June 25: Stryker entered into a definitive agreement to acquire SafeAir, a Swiss medical device company focused on surgical smoke evacuation solutions. The terms of the agreement were not disclosed, although the acquisition is expected to close in the fourth quarter of 2018.

July 10: Stryker made organizational changes to its orthopedics division after Group President of Orthopaedics David Floyd announced his retirement. His responsibilities were shifted to Timothy Scannell, who became president and COO of the company Aug. 1.

August 30: Stryker agreed to acquire K2M, a minimally invasive complex spine surgical solutions company, for $1.4 billion, a 27 percent premium. The acquisition complements Stryker's spine business and will make K2M CEO Eric Major president of the division when the deal closes, which is expected in the fourth quarter of this year.

September 11: Stryker agreed to acquire outstanding shares of Invuity, an advanced photonics and single-use, lighted instruments company, for around $190 million, or $7.40 per share. The cash transaction is expected to close in the fourth quarter and have an immaterial impact on Stryker's earnings.

October 1: Stryker acquired HyperBranch Medical Technology, a privately held company dedicated to developing medial devices based on its proprietary polymers and cross-linked hydrogels, for $220 million. The all-cash transaction is expected to have an immaterial impact on Stryker's 2018 net earnings.

October 12: A group of K2M shareholders filed a lawsuit to block the acquisition by Stryker.

October 17: Stryker filed to extend its anti-trust deadline on the $1.4 billion acquisition of K2M.

October 22: K2M shareholders settled the lawsuit against Stryker attempting to halt the acquisition, after the company released detailed financial projections and statements.

October 23: Stryker completed its acquisition of Invuity for $190 million.

K2M shareholders are expected to vote on the acquisition Nov. 7 and Stryker pushed the deadline to Nov. 16.

More articles on orthopedic devices:
Stryker, NuVasive, DePuy Synthes & more: 12 device company notes
Medacta names new CEO: 3 insights
Stryker to pay $7.8M to settle SEC Foreign Corrupt Practices Act violation charge: 5 things to know

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months